Medical Digest & Congress Report

Dr. Luke Laffin presents the results of the Kardinal Phase 2 study, investigating the efficacy of Tonlamarsen as a novel treatment option for patients with uncontrolled hypertension at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:kardinal-phase-2-study-tonlamarsen-treatment-uncontrolled-hypertension

Prof. Stanislav Henkin and Prof. Daniella Kadian-Dodov lead a comprehensive, case-based exploration of pulmonary embolism management in 2026, tracking the patient journey from initial diagnosis through to long-term recovery strategies at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:pulmonary-embolism-2026-case-based-journey-diagnosis-recovery

Professor Joseph William Rossano presents the highly anticipated results from the Phase 3 Scout-HCM trial, evaluating the efficacy and safety of Mavacamten in symptomatic adolescent patients living with obstructive hypertrophic cardiomyopathy at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:mavacamten-symptomatic-adolescent-patients-obstructive-hcm-re...

Professor Roxana Mehran addresses the critical need for gender-specific approaches in cardiovascular care, discussing strategies and clinical advancements aimed at saving women's hearts at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:saving-womens-hearts

Professor Carol F. Kirkpatrick highlights the most critical updates and clinical recommendations from the 2026 ACC/AHA Dyslipidemia Guideline, focusing on new management targets and therapeutic strategies for lipid disorders at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:highlights-2026-accaha-dyslipidemia-guideline

Professor Peter P. Toth provides a comprehensive update on the latest pharmacological strategies in cardiac prevention, specifically focusing on the evolving roles of hypertension management and incretin-based therapies at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:update-cardiac-prevention-medications-hypertension-and-incretin-focus

Professor Steven E. Nissen presents a critical analysis of the SURPASS-CVOT data, comparing the effects of Tirzepatide and Dulaglutide on expanded cardiorenal outcomes in patients at high cardiovascular risk at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:effects-tirzepatide-vs-dulaglutide-cardiorenal-outcomes-surpass-cvot-analysis

Professor Robert S. Rosenson explores the evolving landscape of lipid management, detailing next-generation treatment options and their potential to transform cardiovascular risk reduction at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:next-generation-lipid-treatment-options

Professor Armando Stabile discusses the latest advancements and precision methods in fine tuning prostate cancer diagnostics at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:fine-tuning-prostate-cancer-diagnostics

Prof. Misa Fister and Prof. Tomaz Goslar evaluate the clinical impact and safety of prehospital heparin administration for patients with STEMI undergoing primary PCI, sharing key findings at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:prehospital-heparin-administration-patients-stemi-undergoing-primary-pci

Professor Roxana Mehran provides an expert review of the most impactful interventional cardiology developments from the ACC 2026 Annual Congress, focusing on new stent technologies, structural heart interventions, and complex PCI outcomes. Video: https://medicaldigest.org/scientific-contents/interview:interventional-cardiology-highlights-acc26

Professor Alberico L. Catapano presents findings from the Phase 3 CORALreef AddOn trial, evaluating the oral PCSK9 inhibitor enlicitide decanoate versus bempedoic acid and ezetimibe in statin-treated patients with hypercholesterolemia. Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-enlicitide-decanoate-results-phase-3-coralreef-addon-trial

Professor Christopher Kramer shares the most significant breakthroughs, late-breaking clinical trials, and key takeaways from the ACC 2026 Annual Congress, summarizing the future of cardiovascular care. Video: https://medicaldigest.org/scientific-contents/interview:highlights-acc26

Professor Mark A. Creager provides an in-depth overview of the newly released 2026 Acute Pulmonary Embolism Guideline, highlighting key updates in clinical management and patient outcomes at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:2026-acute-pulmonary-embolism-guideline

Professor Richard P. Meijer explores the frontier of bladder cancer management, focusing on innovative clinical trials, advanced surgical techniques, and the implementation of predictive tools to improve patient outcomes at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer

Professor Niyati Lobo addresses the critical issue of gender bias in bladder cancer, highlighting how diagnostic delays and misdiagnoses lead to significantly worse clinical outcomes for women with MIBC at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:mibc-there-gender-bias-bladder-cancer-diagnosis-and-treatment-women-experience-delays-misdiagnosis-wo...

Professor Antoine G. van der Heijden explores the most debated topics within the EAU Guidelines, focusing on the latest controversies in pediatric urology and the management of Muscle-Invasive Bladder Cancer (MIBC) at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:guidelines-controversies-paeds-and-mibc

Joran Schoorlemmer presents the results of model validation and the clinical impact of adaptive recurrence risk predictions, focusing on how these tools can optimise follow-up strategies for prostate cancer at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:adaptive-recurrence-risk-predictions-optimise-prostate-cancer-follow-results-model-validation-and...

Professor Yair Lotan examines the clinical utility and future potential of urine biomarkers, focusing on how they are transforming the early detection and surveillance of bladder cancer at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:role-urine-biomarkers-detection-bladder-cancer

Professor Ashkan Mortezavi provides a comprehensive overview of the most significant recent and ongoing clinical trials in bladder and prostate cancer, highlighting their impact on future treatment standards at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:urology-trials-bladder-and-prostate-cancer

Professor Nikhil Vasdev explores the latest advancements in bladder cancer management, focusing on clinical trials, innovative surgical techniques, and the use of predictive tools at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer-trials-techniques-and-predictive-tools

Professor Alessandro Viti discusses the impact of PSMA-PET restaging on disease classification and management, redefining "EMBARK-like" patients in the modern PSMA era at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:redefining-embark-patients-psma-era-impact-psma-pet-restaging-disease-classification-and-management

Karen Middelbo Buch-Olsen and Mads Hvid Poulsen present the highly anticipated results from the PRISMA PET randomized controlled trial, comparing progression-free survival in prostate cancer staging between [¹⁸F]PSMA-1007 PET/ceCT and Na[¹⁸F]F-PET/ceCT at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:progression-free-survival-following-primary-staging...

Professor Arjun Konath Nambiar provides a critical update on the 2026 EAU Guidelines, exploring the latest changes and ongoing controversies in urolithiasis, male and female LUTS, and urological infections at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:2026-eau-guidelines-update-and-controversies-urolithiasis-female-and-male-luts-and-infections-what...

Professor Florian M. E. Wagenlehner discusses the critical role of prophylactic antibiotics in renal cancer surgery and effective strategies for safeguarding patients from postoperative infections at the EAU 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:infections-prophylactic-antibiotics-renal-cancer-surgery-safeguarding-patients-postoperative-infection